Co-Authors
This is a "connection" page, showing publications co-authored by KIM-ANH DO and EDWIN JUSTIN OSTRIN.
Connection Strength
0.701
-
Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. J Clin Oncol. 2023 09 20; 41(27):4360-4368.
Score: 0.227
-
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. Int J Mol Sci. 2022 Aug 11; 23(16).
Score: 0.213
-
Biomarker trajectory for earlier detection of lung cancer. EBioMedicine. 2024 Oct; 108:105377.
Score: 0.062
-
Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health Study. Cancers (Basel). 2024 May 30; 16(11).
Score: 0.060
-
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. J Natl Cancer Inst. 2022 02 07; 114(2):290-301.
Score: 0.051
-
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol. 2022 03 10; 40(8):876-883.
Score: 0.051
-
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. J Natl Cancer Inst. 2017 03 01; 109(3):1-9.
Score: 0.037